Oklo (NYSE:OKLO) Issues Earnings Results

Key Points

• Oklo missed on earnings but exceeded revenue expectations: The company reported a quarterly loss of $0.28 per share versus the $0.16 consensus estimate, while revenue reached $1.21 million—well above the roughly $90,000 forecast and up sharply year over year.
• Groves achieved first criticality in under a year, marking a key technical milestone for Oklo’s isotope-reactor program. The Aurora-INL project also advanced toward its targeted 2028 startup.
• Spending guidance increased significantly: Oklo now expects 2026 operating cash use of $120 million–$150 million and capital expenditures of $400 million–$500 million. Although it has more than $3 billion in cash and marketable securities, meaningful commercial revenue may not begin until 2027 or later.

Oklo (NYSE:OKLO - Get Free Report) released its quarterly earnings results on Friday. The company reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.16) by ($0.12), Zacks reports. The firm had revenue of $1.21 million during the quarter, compared to analyst estimates of $0.09 million. During the same period in the prior year, the company posted ($0.18) EPS. The firm's revenue for the quarter was up 11900.0% on a year-over-year basis.

Here are the key takeaways from Oklo's conference call:

• Groves reached first criticality after transitioning from a greenfield site to an operating isotope reactor in just over 11 months, according to management. Oklo said the project validated its construction, authorization, commissioning, and operating capabilities for future deployments.
• Aurora-INL advanced with DOE approval of its preliminary documented safety analysis, site mobilization, and reactor-area excavation nearing completion; the company continues to target a 2028 startup. Oklo also expanded Ohio campus execution planning through an MOU with Kiewit and continued PJM interconnection work.
• Oklo is pursuing a diversified fuel strategy spanning EBR-II material, a potential DOE plutonium allocation, Centrus commercial HALEU, and future recycling. The Centrus letter of intent could support initial core and reload needs for up to five Aurora powerhouses, although it remains subject to a definitive agreement and deliveries are expected from 2029.
• The company strengthened its vertically integrated platform through acquisitions of ARMEC and Creative Engineers, adding engineering, manufacturing, testing, and sodium-systems capabilities. Oklo also highlighted collaborations with NVIDIA, Los Alamos National Laboratory, and DOE initiatives to apply AI to fuel qualification, reactor design, and operational workflows.
• Oklo raised its 2026 guidance for operating cash use to $120 million–$150 million from $80 million–$100 million and property, plant, and equipment spending to $400 million–$500 million from $350 million–$450 million. The company ended the quarter with more than $3 billion in cash and marketable securities, but isotope revenue is not expected to begin meaningfully until potentially early 2027, primarily from the Idaho laboratory rather than Groves.

Oklo Price Performance

Shares of OKLO stock traded up $6.19 during trading hours on Friday, reaching $48.38. 22,043,558 shares of the stock were exchanged, compared to its average volume of 8,689,262. The business's fifty day moving average is $50.88 and its two-hundred day moving average is $60.58. Oklo has a 12-month low of $36.61 and a 12-month high of $193.84. The firm has a market capitalization of $8.42 billion, a P/E ratio of -57.59 and a beta of 1.17.

Key Oklo News

Here are the key news stories impacting Oklo this week:

• Positive Sentiment: First quarterly revenue beat expectations. Oklo reported Q2 revenue of $1.21 million, far above the approximately $90,000 consensus estimate and up sharply year over year. The result provided an early indication of potential commercial activity, despite revenue remaining very small. Oklo Publishes Second Quarter 2026 Financial Results and Business Update
• Positive Sentiment: Groves reactor reached first criticality. Oklo’s Groves Isotope Test Reactor in Texas achieved a controlled, self-sustaining chain reaction at low power less than a year after groundbreaking. The DOE-authorized milestone supports initial isotope-production testing and strengthens the company’s technical and execution case for future reactor projects, including potential data-center power applications. Oklo’s Groves Reactor Achieves First Criticality in Under a Year
• Neutral Sentiment: Investors still face a long commercialization timeline. Management and market commentary indicate that meaningful power-generation revenue may not arrive until 2027–2028. Oklo’s substantial cash reserves provide funding for licensing, development and construction, but the stock’s valuation remains dependent on successful regulatory approvals and project execution. Oklo Q2 2026 Earnings Call Transcript
• Negative Sentiment: Quarterly losses were wider than expected. Oklo reported an adjusted loss of $0.28 per share versus the $0.16 consensus estimate, reflecting continued heavy development spending. The company remains unprofitable, making future financing needs and execution particularly important for shareholders. Oklo Quarterly Earnings Results
• Negative Sentiment: Insider selling remains a risk signal. Reported open-market activity over the past six months showed numerous insider sales and no purchases, including substantial sales by co-founders Jacob DeWitte and Caroline Cochran. This may weigh on sentiment, even though sales can also reflect scheduled transactions or diversification. Oklo Stock Opinions on Reactor Criticality Milestone

Insider Activity at Oklo

In related news, insider William Carroll Murphy Goodwin sold 10,548 shares of Oklo stock in a transaction that occurred on Wednesday, May 20th. The shares were sold at an average price of $58.04, for a total value of $612,205.92. Following the completion of the transaction, the insider owned 36,175 shares in the company, valued at $2,099,597. The trade was a 22.58% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Jacob Dewitte sold 60,000 shares of the business's stock in a transaction that occurred on Wednesday, July 1st. The stock was sold at an average price of $52.80, for a total transaction of $3,168,000.00. Following the transaction, the chief executive officer owned 511,533 shares of the company's stock, valued at $27,008,942.40. This trade represents a 10.50% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 483,629 shares of company stock valued at $29,855,608 over the last 90 days. 12.70% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Oklo

Several large investors have recently bought and sold shares of OKLO. Wilmington Savings Fund Society FSB purchased a new stake in Oklo during the 3rd quarter worth about $45,000. Gilpin Wealth Management LLC purchased a new position in shares of Oklo in the 4th quarter valued at about $29,000. Triumph Capital Management acquired a new stake in shares of Oklo during the 3rd quarter worth about $49,000. Kemnay Advisory Services Inc. acquired a new stake in shares of Oklo during the 4th quarter worth about $35,000. Finally, Litman Gregory Wealth Management LLC purchased a new stake in Oklo during the fourth quarter worth approximately $36,000. Hedge funds and other institutional investors own 85.03% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on the company. Wolfe Research started coverage on Oklo in a research note on Tuesday, May 19th. They set a "peer perform" rating on the stock. Barclays cut their price target on shares of Oklo from $82.00 to $76.00 and set an "overweight" rating on the stock in a research note on Wednesday, July 22nd. Guggenheim initiated coverage on shares of Oklo in a research report on Thursday, June 25th. They set a "neutral" rating on the stock. Truist Financial began coverage on shares of Oklo in a report on Monday, July 13th. They issued a "hold" rating and a $55.00 price objective for the company. Finally, Wedbush restated an "outperform" rating and issued a $110.00 price objective on shares of Oklo in a report on Tuesday, May 26th. One equities research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating, ten have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Oklo currently has an average rating of "Moderate Buy" and an average price target of $88.00.

Oklo Company Profile

Oklo, Inc is a California-based energy technology company specializing in the design and development of advanced nuclear microreactors. Headquartered in Fremont, the firm focuses on small modular reactor (SMR) technology that leverages fast-neutron fission and liquid-metal cooling to deliver carbon-free power. Oklo’s core objective is to bring compact, factory-built reactors online within a decade, offering a low-footprint alternative to traditional large nuclear plants.

The company’s flagship product, the Aurora microreactor, is a 1.5-megawatt electric (MWe) fast reactor cooled by a sodium alloy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source